SEMA4A and neoplasm: Sema4A expression enhances B-cell infiltration, which contributes to favorable outcome for head and neck squamous cell carcinoma (28), and Sema4A expression on DCs activates CTL and exerts anti-tumor in Lewis lung cancer (29), whereas Sema4A maintains the stability and function of Tregs in melanoma (30).